Coronavirus SARS-CoV-2 infection: neurological disorders recommendations

Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .

Coronavirus SARS-CoV-2 infection: neurological disorders recommendations. People in high risk disease category. Fully referenced neurology checklist.

Recommendations for self-isolation

  • People in high risk disease category
  • Lower risk category associated with medical co-morbidity
  • Lower risk category associated with bulbar features

Recommendations to continue medications

Locked: subscribe to see this section.

General recommendations for immunosuppressants

Locked: subscribe to see this section.

Recommendations to delay medications

Locked: subscribe to see this section.

Recommendations for steroids

Locked: subscribe to see this section.

Recommendations if COVID-19 infected

Locked: subscribe to see this section.

Myasthenia gravis (MG) and Lambert Eaton myasthenic syndrome (LEMS)

Locked: subscribe to see this section.

Other recommendations

Locked: subscribe to see this section.

Multiple sclerosis (MS)

Locked: subscribe to see this section.

Synonym

Locked: subscribe to see this section.

References

  1. Association of British Neurologists Guidance on COVID-19 for people with neurological conditions, their doctors and carers. ABN 2020. Accessed 03.04.2020.
  2. von Oertzen TJ, Macerollo A, Leone MA, et al. EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic. Eur J Neurol 2021; 28:7-14. 
  3. NHS England. Clinical guide for the management of patients with musculoskeletal and rheumatic conditions on corticosteroids during the coronavirus pandemic. NHS England Accessed 03.04.2020.
  4. International MG/COVID-19 Working Group. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during COVID-19 pandemic. J Neurol Sci 2020; 412:116803.

Related checklists

Loading...